US IPO Pipeline SEC S-1 Filings — April 09, 2026

09-04-2026

AMASS Brands filed an S-1 registration statement on April 8, 2026, for a direct listing/IPO, disclosing board committee structures, code of conduct, and executive compensation for fiscal years 2024 and 2025. Named executive officer total compensation showed mixed results: CEO Mark T. Lynn's salary increased ~20% to $200,600 with flat total comp, COO Erin K. Green's total rose significantly to $1,192,600 driven by $992,000 in options (salary flat at ~$200,600), while no bonuses were paid to any NEOs and former interim CFO Geoffrey McFarlane's pay declined slightly to $240,000. The company plans post-listing compensation adjustments and equity grants under the 2016 Stock Option Plan.

• ·No employer matching or nonelective contributions to 401(k) Plan in FY2024 or FY2025.
• ·All committee members (Audit, Compensation, Nominating) determined independent per Nasdaq and SEC rules.
• ·Zach Ament eligible for pro-rata $40,000 bonus upon direct listing closing.

09-04-2026

RMX Industries, Inc. (formerly Reticulate Micro, Inc., name changed March 23, 2023) filed an S-1 registration statement on April 9, 2026, to register securities under the 1933 Act, signaling preparation for an initial public offering. The filing incorporates by reference over 70 exhibits, including private placement subscription agreements and promissory notes from 2022 to 2026, multiple executive employment, consulting, and separation agreements, IP licenses and purchases, leases, joint ventures, escrow agreements, and amendments to the 2022 Equity Incentive Plan. No financial performance metrics, period-over-period comparisons, or specific monetary amounts are detailed in the provided filing content.

• ·Incorporated in Nevada (EIN: 882960484)
• ·Fiscal year end: December 31
• ·Business address: 4514 Cole Ave, Ste. 600, Dallas, TX 75205
• ·SIC: 7370 (Services-Computer Programming, Data Processing, etc.)
• ·SEC file number: 333-294940

09-04-2026

Jersey Central Power & Light Co. (JCP&L), a FirstEnergy subsidiary, filed an S-4 registration statement on April 9, 2026, in connection with a business combination, including historical financial data and operating segment details. Affiliated operating expenses totaled $116 million in 2025 (down 1.7% from $118 million in 2024) and $118 million in 2024 (down 3.3% from $122 million in 2023), reflecting modest YoY declines. The filing references restatements for 2023 and 2024, related party transactions with FirstEnergy, and equity grants to employees via the 401(k) Savings Plan, but lacks full income statement or balance sheet metrics.

• ·Restatement adjustments noted for 2023 and 2024 periods.
• ·FE common equity granted to JCP&L employees primarily for 401(k) Savings Plan.
• ·References to regulated distribution, standalone transmission, and integrated segments with customer breakdowns (residential, commercial, industrial, other).

09-04-2026

Aptera Motors Corp, an automotive technology company developing highly efficient solar electric vehicles (SEVs) like its flagship three-wheeled Aptera, filed an S-1 registration statement to allow selling stockholders to offer up to 4,751,250 shares of Class B Common Stock upon warrant exercise, with proceeds from cash exercises intended for working capital. The company has not yet commenced production and faces significant challenges including scaling production, competition, technical risks, and funding needs. As an emerging growth company with less than $1.235B in revenue, it benefits from reduced disclosure requirements but highlights high investment risks.

• ·Company formed on March 4, 2019, as a Delaware public benefit corporation headquartered in Carlsbad, California.
• ·Common Stock listed on Nasdaq Capital Market under symbol 'SEV'.
• ·Annual Report on Form 10-K for fiscal year ended December 31, 2025, filed with SEC on March 30, 2026.

09-04-2026

BioLargo, Inc. (BLGO) filed an S-1 registration statement on April 9, 2026, to register securities, likely supporting an equity offering or sales under its Lincoln Park Capital Fund LLC facility. Common shares outstanding increased 5.3% to 317,377,777 as of December 31, 2025, from 301,274,243 at year-end 2024, reflecting dilution from debt conversions and issuances. The company reports customer concentration risk with one customer and past-due receivables, including a royalty receivable overdue since June 6, 2025.

• ·Authorized common stock: 550,000,000 shares at par value $0.00067.
• ·Partially owned subsidiaries include BETI and Clyra Medical Technologies.
• ·Royalty receivable past due as of June 6, 2025; product invoice receivable past due same date.
• ·Customer A represents concentration risk in revenue and accounts receivable for 2025 and 2024.
• ·Subsequent events include Clyra Medical unsecured debt through March 4, 2026.